DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma. 1986

S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin

Flow cytometry studies for cellular DNA analysis were performed in 115 cases of non-Hodgkin's lymphoma, 53 of which had not received any prior chemotherapy or radiotherapy. DNA content was measured in ethanol fixed cells stained with chromomycin A3. According to the criteria of the International Working Formulation there were 43 low grade, 58 intermediate grade, and eight high grade lymphomas; six cases were in the miscellaneous group. Seventy seven (67%) had only diploid DNA content. Thirty eight (33%) showed DNA aneuploidy; 20 of these had been previously treated with chemotherapy or radiotherapy, or both. DNA aneuploidy was seen as hyperdiploidy in all cases except one, and it varied from slightly hyperdiploid to tetraploid. The incidence of aneuploidy increased significantly with increasing histological grade (p = 0.0002) and was not related to previous treatment. The low, intermediate, and high grade lymphomas had 14% (six of 43), 47% (27 of 58), and 62.5% (five of eight) cases, respectively, that showed DNA aneuploidy. The percentage of cells in S phase increased significantly with a higher histological grade (p less than 0.0001). The median S fraction in the low, intermediate, and high grade lymphomas was 1.0 (0.5 to 10)% 4 (0.4 to 35)%, and 27 (4.6-56)%, respectively. There is a significant correlation between histological grade and S fraction and the presence or absence of aneuploidy. There is heterogeneity, however, within both histological grade and a histological subtype.

UI MeSH Term Description Entries
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000782 Aneuploidy The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1). Aneuploid,Aneuploid Cell,Aneuploid Cells,Aneuploidies,Aneuploids,Cell, Aneuploid,Cells, Aneuploid

Related Publications

S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
April 1993, Experimental hematology,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
January 1994, Acta haematologica Polonica,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
July 1992, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
January 1993, Acta haematologica Polonica,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
January 1997, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
November 1995, Blood,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
October 1986, British journal of cancer,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
November 1997, Leukemia & lymphoma,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
March 1991, Journal of clinical pathology,
S K Juneja, and I A Cooper, and G S Hodgson, and M M Wolf, and J C Ding, and P N Ironside, and R J Thomas, and J D Parkin
February 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!